We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current BCAB market cap is 30M. The company's latest EPS is USD -2.5537 and P/E is -0.24.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 11M |
| Operating Income | -35.02M | -28.54M | -24.46M | -21.97M | -11.27M |
| Net Income | -33.33M | -26.93M | -23.23M | -21.07M | -10.59M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 5.2M | 429k | 250k | 0 | 0 |
| Operating Income | -28.27M | -30.1M | -96.44M | -108.14M | -129.69M |
| Net Income | -28.73M | -35.85M | -95.4M | -106.48M | -123.46M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 151.36M | 119.66M | 89.2M | 68.64M | 62.24M |
| Total Liabilities | 56.66M | 48.99M | 39.48M | 37.27M | 39.27M |
| Total Equity | 94.7M | 70.67M | 49.72M | 31.37M | 22.97M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 9.34M | 244.94M | 254.42M | 225.74M | 119.66M |
| Total Liabilities | 65.35M | 34.96M | 43.6M | 45.4M | 48.99M |
| Total Equity | -56.01M | 209.97M | 210.82M | 180.34M | 70.67M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -74.09M | -104.02M | -30.83M | -50.02M | -55.15M |
| Investing | -90k | -98k | N/A | N/A | N/A |
| Financing | -42k | 77k | -13k | 212k | 198k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.65M | -36.33M | -62.21M | -90.42M | -104.02M |
| Investing | -1.51M | -590k | -924k | -265k | -98k |
| Financing | 4M | 271.83M | 69.51M | 61.21M | 77k |
| Market Cap | 30M |
| Price to Earnings Ratio | -0.24 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.27 |
| Price to Book Ratio | 0.42 |
| Dividend Yield | - |
| Shares Outstanding | 48.35M |
| Average Volume (1 week) | 2.22M |
| Average Volume (1 Month) | 929.23k |
| 52 Week Change | -72.05% |
| 52 Week High | 4.02 |
| 52 Week Low | 0.61 |
| Spread (Intraday) | 0.01 (1.19%) |
| Company Name | BioAtla Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.bioatla.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
